标题
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
作者
关键词
-
出版物
Biomedicines
Volume 10, Issue 4, Pages 760
出版商
MDPI AG
发表日期
2022-03-25
DOI
10.3390/biomedicines10040760
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis
- (2022) Eleonora Virgilio et al. JOURNAL OF NEUROLOGY
- Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
- (2022) Leonidas Chouliaras et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- An Electrochemiluminescence Biosensor for the Detection of Alzheimer’s Tau Protein Based on Gold Nanostar Decorated Carbon Nitride Nanosheets
- (2022) Roghayeh Jalili et al. MOLECULES
- Tau protein as a diagnostic and prognostic biomarker in Amyotrophic Lateral Sclerosis
- (2021) Luisa Agnello et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis
- (2021) Sara Momtazmanesh et al. REVIEWS IN THE NEUROSCIENCES
- A Pharmacokinetic and Biomarker Study of Delayed-Release Dimethyl Fumarate in Subjects with Secondary Progressive Multiple Sclerosis: Evaluation of Cerebrospinal Fluid Penetration and the Effects on Exploratory Biomarkers
- (2021) Keith R. Edwards et al. Multiple Sclerosis and Related Disorders
- Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?
- (2021) Fabiola De Marchi et al. NEUROLOGICAL SCIENCES
- Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
- (2021) Tien Dam et al. NATURE MEDICINE
- Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- (2021) Federico Verde et al. Frontiers in Neuroscience
- 18F-MK-6240 tau-PET in genetic frontotemporal dementia
- (2021) Jake P Levy et al. BRAIN
- Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
- (2021) Yuta Kojima et al. PLoS One
- Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis
- (2021) Eleonora Virgilio et al. Multiple Sclerosis and Related Disorders
- Serum Vitamin D as a Marker of Impaired Information Processing Speed and Early Disability in Multiple Sclerosis Patients
- (2021) Eleonora Virgilio et al. Brain Sciences
- Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
- (2020) Burcu Zeydan et al. ANNALS OF NEUROLOGY
- Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis
- (2020) Samir Abu-Rumeileh et al. JOURNAL OF NEUROLOGY
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case report
- (2020) Abbie S. Ornelas et al. PARKINSONISM & RELATED DISORDERS
- Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis
- (2020) Débora Lanznaster et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Progressive supranuclear palsy: Advances in diagnosis and management
- (2020) David G. Coughlin et al. PARKINSONISM & RELATED DISORDERS
- Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
- (2020) Giovanni Schepici et al. Brain Sciences
- Biomarkers in amyotrophic lateral sclerosis
- (2020) Nick Verber et al. CURRENT OPINION IN NEUROLOGY
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
- (2020) C. Delaby et al. Scientific Reports
- Tau at the interface between neurodegeneration and neuroinflammation
- (2020) Alessandro Didonna GENES AND IMMUNITY
- Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
- (2020) Ralph H B Benedict et al. LANCET NEUROLOGY
- Serum neurofilament light chain
- (2020) Orhan Aktas et al. Neurology-Neuroimmunology & Neuroinflammation
- Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease
- (2020) Ignacio Illán-Gala et al. NEUROLOGY
- Intrathecal kappa free light chains as markers for multiple sclerosis
- (2020) D. Vecchio et al. Scientific Reports
- Blood Neurofilament Light Chain: The Neurologist’s Troponin?
- (2020) Simon Thebault et al. Biomedicines
- A walk through tau therapeutic strategies
- (2019) Santosh Jadhav et al. Acta Neuropathologica Communications
- 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
- (2019) Richard M. Tsai et al. Alzheimers Research & Therapy
- Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis
- (2019) et al. ANNALS OF NEUROLOGY
- Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
- (2019) Martha S Foiani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Classifying silent progression in relapsing–remitting MS
- (2019) Massimo Filippi et al. Nature Reviews Neurology
- K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up
- (2019) Ilaria Crespi et al. Journal of Clinical Medicine
- Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
- (2019) Adam L Boxer et al. LANCET NEUROLOGY
- New evidence on the management of Lewy body dementia
- (2019) John-Paul Taylor et al. LANCET NEUROLOGY
- Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects
- (2019) Pascale Barbier et al. Frontiers in Aging Neuroscience
- Parkinson disease
- (2019) R. Balestrino et al. EUROPEAN JOURNAL OF NEUROLOGY
- Molecular biomarkers in multiple sclerosis
- (2019) Tjalf Ziemssen et al. Journal of Neuroinflammation
- Serum and saliva total tau protein as a marker for relapsing-remitting multiple sclerosis
- (2019) Mohammad-Hossein Mirzaii-Dizgah et al. MEDICAL HYPOTHESES
- Tau Tangles in Parkinson’s Disease: A 2-Year Follow-Up Flortaucipir PET Study
- (2019) Allan K. Hansen et al. Journal of Parkinsons Disease
- BDNF and Tau as biomarkers of severity in multiple sclerosis
- (2018) Azul Islas-Hernandez et al. Biomarkers in Medicine
- Plasma tau is increased in frontotemporal dementia
- (2018) Martha S Foiani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
- (2018) Lieke H.H. Meeter et al. NEUROLOGY
- Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease
- (2018) Joseph R. Winer et al. JAMA Neurology
- CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
- (2018) Peter Körtvelyessy et al. Frontiers in Neurology
- Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
- (2018) Mahsa Dolatshahi et al. Frontiers in Neurology
- Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia
- (2018) Karin Gmitterová et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis
- (2018) Antonio Scarafino et al. JOURNAL OF NEUROLOGY
- Significance of CSF NfL and tau in ALS
- (2018) Stefanie Schreiber et al. JOURNAL OF NEUROLOGY
- Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42 profiles in a prospective longitudinal study
- (2018) Stefanie Lerche et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease
- (2018) Gennaro Pagano et al. NEUROLOGY
- Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
- (2018) Peter A. Ljubenkov et al. Annals of Clinical and Translational Neurology
- Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study
- (2018) Samir Abu-Rumeileh et al. JOURNAL OF ALZHEIMERS DISEASE
- Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study
- (2018) Manuel Delgado-Alvarado et al. MOVEMENT DISORDERS
- Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis
- (2017) Zhang-Yu Zou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
- (2017) Anette Schrag et al. LANCET NEUROLOGY
- In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography
- (2017) Allan K. Hansen et al. MOVEMENT DISORDERS
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
- (2017) J.A. Obeso et al. MOVEMENT DISORDERS
- Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
- (2017) Brit Mollenhauer et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- In vivo retention of 18 F-AV-1451 in corticobasal syndrome
- (2017) Ruben Smith et al. NEUROLOGY
- ALS and frontotemporal dementia belong to a common disease spectrum
- (2017) P. Couratier et al. REVUE NEUROLOGIQUE
- Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
- (2017) Michael J. Strong et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
- (2016) Ju-Hee Kang et al. ACTA NEUROPATHOLOGICA
- 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers
- (2016) Ruben Smith et al. BRAIN
- In vivoimaging of neuromelanin in Parkinson’s disease using18F-AV-1451 PET
- (2016) Allan K. Hansen et al. BRAIN
- Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
- (2016) J. Mellergård et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
- (2016) Lenka Novakova et al. JOURNAL OF NEUROCHEMISTRY
- α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology
- (2016) Josefine R. Christiansen et al. Journal of Neuroinflammation
- Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies
- (2016) Franc Llorens et al. JOURNAL OF NEUROLOGY
- Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers
- (2016) Dolores Vilas et al. MOVEMENT DISORDERS
- Subcortical18F-AV-1451 binding patterns in progressive supranuclear palsy
- (2016) Hanna Cho et al. MOVEMENT DISORDERS
- CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis
- (2016) Anna M Pietroboni et al. Multiple Sclerosis Journal
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
- (2016) Stephen N. Gomperts et al. JAMA Neurology
- CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis
- (2016) Anna M Pietroboni et al. Multiple Sclerosis Journal
- [18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
- (2016) W. Richard Bevan Jones et al. Annals of Clinical and Translational Neurology
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
- (2015) Lauren Walker et al. ACTA NEUROPATHOLOGICA
- Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
- (2015) Marta Marquié et al. ANNALS OF NEUROLOGY
- Role of amyloid-β CSF levels in cognitive deficit in MS
- (2015) Antonietta Gentile et al. CLINICA CHIMICA ACTA
- Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too
- (2015) Gorkem Kosehasanogullari et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis
- (2015) Carlo Wilke et al. NEUROBIOLOGY OF AGING
- CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
- (2015) Changqin Liu et al. PARKINSONISM & RELATED DISORDERS
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
- (2015) Megan K. Herbert et al. Frontiers in Neurology
- New Multiple Sclerosis Phenotypic Classification
- (2014) Fred D. Lublin EUROPEAN NEUROLOGY
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- The phenotypic variability of amyotrophic lateral sclerosis
- (2014) Bart Swinnen et al. Nature Reviews Neurology
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
- (2014) Barbara Borroni et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
- (2014) Murray Grossman et al. JAMA Neurology
- Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
- (2013) Jing Zhang et al. ACTA NEUROPATHOLOGICA
- [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
- (2013) Chun-Fang Xia et al. Alzheimers & Dementia
- α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease-Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model
- (2013) Vanesa Sanchez-Guajardo et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Cerebrospinal Fluid Tau Levels Predict Prognosis in Non-Inherited Frontotemporal Dementia
- (2013) Barbara Borroni et al. Neurodegenerative Diseases
- Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP
- (2013) W. T. Hu et al. NEUROLOGY
- Neuropathology of dementia in a large cohort of patients with Parkinson's disease
- (2013) Judit Horvath et al. PARKINSONISM & RELATED DISORDERS
- CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls
- (2013) Megan K. Herbert et al. PARKINSONISM & RELATED DISORDERS
- Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
- (2013) Ju-Hee Kang JAMA Neurology
- Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults
- (2012) Donata Paternicò et al. Alzheimers & Dementia
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy
- (2012) Jacek Jaworski et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
- (2011) Argonde C. van Harten et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease
- (2011) Thomas Haggerty et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- CSF biomarkers in different phenotypes of Parkinson disease
- (2011) Kurt A. Jellinger JOURNAL OF NEURAL TRANSMISSION
- Tau protein and beta-amyloid1-42 CSF levels in different phenotypes of Parkinson’s disease
- (2011) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis
- (2011) J Frederiksen et al. Multiple Sclerosis Journal
- Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
- (2011) N. S. M. Schoonenboom et al. NEUROLOGY
- Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone
- (2010) H. Bartosik-Psujek et al. ACTA NEUROLOGICA SCANDINAVICA
- Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
- (2010) Alexis Elbaz et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons
- (2010) Eun S Chung et al. BMC NEUROSCIENCE
- CSF markers of neurodegeneration in Parkinson’s disease
- (2010) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes
- (2010) Sigurd D. Süssmuth et al. MOVEMENT DISORDERS
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- CSF glial markers correlate with survival in amyotrophic lateral sclerosis
- (2010) S. D. Sussmuth et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Cognitive and Cortical Plasticity Deficits Correlate with Altered Amyloid-β CSF Levels in Multiple Sclerosis
- (2010) Francesco Mori et al. NEUROPSYCHOPHARMACOLOGY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson’s disease models
- (2009) Tetyana Duka et al. FASEB JOURNAL
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
- (2008) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis
- (2008) Katharina Hein (née Maier) et al. NEUROSCIENCE LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search